Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 · New England Journal of Medicine · 3,145 citations
https://doi.org/10.1056/nejmoa1812792
T
Terry A. Jacobson
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
300
Papers
27.0K
Citations
81
h-index
179
i10-index
Terry A. Jacobson is an academic researcher from Emory University. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Diabetes, Cardiovascular Risks, and Lipoproteins & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 81, co-authored 255 publications.
ORCID: 0000-0002-9926-2179Papers by this author
worksStatin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
2015 · European Heart Journal · 1,368 citations
https://doi.org/10.1093/eurheartj/ehv043
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
2015 · European Heart Journal · 1,368 citations
https://doi.org/10.1093/eurheartj/ehv043
Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) among Low-Literacy Patients with Chronic Disease
2008 · Value in Health · 481 citations
https://doi.org/10.1111/j.1524-4733.2008.00400.x
Statin-induced myopathy: a review and update
2011 · Expert Opinion on Drug Safety · 314 citations
https://doi.org/10.1517/14740338.2011.540568
Effects of Icosapent Ethyl on Total Ischemic Events
2019 · Journal of the American College of Cardiology · 248 citations
https://doi.org/10.1016/j.jacc.2019.02.032
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat